drugset / Trial / NCT07031011
PD-1-M1-NK Cells in the Treatment of Advanced Gastric or Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is an Early Clinical Study to Investigate the Safety, Pharmacokinetics, and Efficacy of PD-1-M1-NK Cells (YC-T-001) in Patients with Advanced Gastric or Colorectal Cancer Failed or Intolerant to at Least Second-line Therapy.
Timeline
- Start
- 2025-06-30
- Primary completion
- 2027-01-31
- Completion
- 2027-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PD-1-M1-NK Cells | Unknown | 5e+06 cells/kg | Other |
| Subject | PD-1-M1-NK Cells | Unknown | 1e+07 cells/kg | Other |
| Subject | PD-1-M1-NK Cells | Unknown | 2e+07 cells/kg | Other |
| Subject | PD-1-M1-NK Cells | Unknown | 5e+07 cells/kg | Other |